Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?
Autor
Velilla, T.A.
Guijarro, C.
Ruiz, R.C.
Piñero, M.R.
Marcos, J.F.V.
Pérez, A.P.
López, M.A.B.
López, A.M.
Donaire, J.A.G.
Obaya, J.C.
Guerra, L.C.
Carratalá, V.P.
Cabello, I.E.
Lazo, M.S.
Rodrigo, M.M.C.
Prieto, J.M.M.
Doblas, J.J.G.
Soto, A.B.
Resumen
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. © 2023 The Authors
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Physical exercise, detraining and lipid profile in obese children: A systematic review (2020)
García-Hermoso A.; Carmona-López M.I.; Saavedra J.M.; Escalante Y. (Sociedad Argentina de Pediatria, 2014) -
Article
Gender differences on effectiveness of a school-based physical activity intervention for reducing cardiometabolic risk: A cluster randomized trial (2020)
Martínez-Vizcaíno V.; Sánchez-López M.; Notario-Pacheco B.; Salcedo-Aguilar F.; Solera-Martínez M.; Franquelo-Morales P.; López-Martínez S.; García-Prieto J.C.; Arias-Palencia N.; Torrijos-Niño C.; ... (BioMed Central Ltd., 2014) -
Article
Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome [Incremento de lipoproteína(a) en paciente pediátrico asociado a síndrome nefrótico] (2020)
Menéndez Valladares P.; Arrobas Velilla T.; Bermúdez de la Vega J.A.; Romero Pérez M.D.M.; Fabiani Romero F.; González Rodríguez C. (Elsevier Doyma, 2016)